Betterment LLC
IBB icon

Betterment LLC’s iShares Biotechnology ETF IBB Stock Holding History

Betterment LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Sell
1,064
-260
-20% -$44.7K ﹤0.01% 667
2026
Q1 		$224K Buy
+1,324
New +$226K ﹤0.01% 585

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Betterment LLC's IBB Position: Q2 2026 in Review

Betterment LLC reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q2 2026, selling an estimated $44.7K and leaving 1,064 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Betterment LLC first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. The position peaked at $224K in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Betterment LLC held 1,064 shares of iShares Biotechnology ETF worth $202K as of Q2 2026.
  • Betterment LLC sold 260 iShares Biotechnology ETF shares in Q2 2026, an estimated $44.7K.
  • iShares Biotechnology ETF made up ﹤0.01% of Betterment LLC's portfolio in Q2 2026, its #667 holding.
  • Betterment LLC first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • Betterment LLC's iShares Biotechnology ETF position peaked at $224K in Q1 2026.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Betterment LLC's 13F filing for Q2 2026, filed 14 Aug 2026.